Other chemotherapy drugs such as bortezomib and salubrinal induce eIF2α phosphorylation indirectly [224], resulting in anti-tumor effects, further reinforcing the potential for the combination of chemotherapy and eIF2α in synergistic tumor cell kill. The gene discussed is EIF2A; the disease is neoplasm.